Stock Earnings

Question 1

How did BCAX's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Bicara Therapeutics Inc is $-0.5, not beating expectations of $-0.57.

Question 2

How did Bicara Therapeutics Inc BCAX's revenue perform in the last quarter?

Accepted Answer

Bicara Therapeutics Inc revenue for the last quarter is $-0.5

Question 3

What is the revenue estimate for Bicara Therapeutics Inc?

Accepted Answer

According to 10 of Wall street analyst, the revenue estimate of Bicara Therapeutics Inc range from $0.0 to $0.0

Question 4

What's the earning quality score for Bicara Therapeutics Inc?

Accepted Answer

Bicara Therapeutics Inc has a earning quality score of B+/48.743683. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Bicara Therapeutics Inc report earnings?

Accepted Answer

Bicara Therapeutics Inc next earnings report is expected in 2025-11-10

Question 6

What are Bicara Therapeutics Inc's expected earnings?

Accepted Answer

Bicara Therapeutics Inc expected earnings is $0.0, according to wall-street analysts.

Question 7

Did Bicara Therapeutics Inc beat earnings expectations?

Accepted Answer

Bicara Therapeutics Inc recent earnings of $0.0 does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '25	$-0.57	$-0.5	-12.28%	MISSED
Q1 '25	$-0.42	$-0.68	+61.9%	BEAT
Q4 '24	$-0.32	$-0.39	+21.87%	BEAT
Q3 '24	$-0.46	$-1.6	+247.82%	BEAT

Bicara Therapeutics Inc (BCAX) Price

BCAX Stock Price Chart

Latest Earnings Results: Q2 '25

Historical Earnings

Earnings FAQ